With continued investment and global cooperation, a world free from malaria may no longer be a distant dream but an imminent reality.... Dec 20
The FDA Science Forum is a platform for researchers and scientists which gives them the opportunity to showcase their scientific and evidence-based work for ... May 19
The latest studies claim 76% efficacy, DSMB still has doubts... Mar 25
Pregnant women who are infected with SARS-CoV-2, the virus that causes COVID-19, during the third trimester are unlikely to pass the infection ... Dec 23
CPI-818, an oral interleukin-2-inducible T-cell kinase inhibitor, is well-tolerated and active in patients with T-cell lymphoma... Dec 07
This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel... Dec 05
Bamlanivimab received emergency use authorization (EUA) from the U.S. Food and Drug Administration on November 9, 2020... Nov 23
This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines... Nov 19
It took only 6 weeks for biotech major to develop the mRNA based covid vaccine... Oct 31
ViralClear Pharmaceuticals, Inc. announced the halting of its signal finding Phase 2 hospitalized Covid-19 trial.... Oct 27
Approximately 100 hospitalized volunteers will be assigned to each study arm with each of the study sites testing no more than three investigational treatments at ... Oct 14
That mutation is associated with a higher viral load among patients upon initial diagnosis, the researchers found.... Sep 24
The Company is committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use... Sep 23
PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibodies to treat cancer and neovascular disease... Sep 22
HDT Bio Corp. received a notice of award from the National Institute of Allergy and Infectious Disease at the National Institutes of Health... Sep 02
AstraZeneca closer to COVID vaccine as 3rd phase trial starts... Sep 01
Blood Plasma Therapy gets approval in US... Aug 24
The vaccine, called mRNA-1273, is being co-developed by Moderna and the NIH's National Institute of Allergy and Infectious Diseases (NIAID)... Aug 12
More than 40 percent of coronavirus deaths in the U.S. linked to long-term care facilities;... Aug 03
Phase 1 trials establishes the safety level of Moderna's vaccine candidate... Jul 16
Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate ... Jul 10
ELI Lilly close to coronavirus antiviral as 3rd phase trial begins... Jun 17
As countries emerge warily from lockdowns, leaders are looking to a preventive shot as the route to return to pre-pandemic life... Jun 16
The authors said that they have submitted the work to a top-tier journal... Jun 15
This is the barest beginning of preliminary information," said Dr. Gregory Poland, an immunologist and vaccine researcher at the Mayo Clinic... Jun 13
-Advertisements-
-23-300x250.png)
.jpeg)
Thursday, October 29, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
